High intraluminal pressure via H2O2 upregulates arteriolar constrictions to angiotensin II by increasing the functional availability of AT1 receptors

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 295, Issue 2, 2008, Pages

  Bagi, Zsolt ^a,b   Erdei, Nora ^b   Koller, Akos ^a,c  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Hydrogen peroxide; Hypertension; Oxidative stress

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; CATALASE; DIPEPTIDYL CARBOXYPEPTIDASE; HYDROGEN PEROXIDE; MACROGOL; NORADRENALIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; TIRON; ANTIOXIDANT; CATALASE POLYETHYLENE GLYCOL; CATALASE-POLYETHYLENE GLYCOL; MACROGOL DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTERY CONSTRICTION; ARTERY WALL; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG RECEPTOR BINDING; INTRAARTERIAL LUMINAL PRESSURE; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRESSURE MEASUREMENT; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TACHYPHYLAXIS; VASCULAR RESISTANCE; ANIMAL; ARTERIOLE; BLOOD PRESSURE; DRUG EFFECT; HYPERTENSION; IN VITRO STUDY; METABOLISM; OXIDATIVE STRESS; UPREGULATION; VASCULARIZATION; VASOCONSTRICTION; WISTAR RAT;

ANGIOTENSIN II; ANIMALS; ANTIOXIDANTS; ARTERIOLES; BLOOD PRESSURE; CATALASE; HYDROGEN PEROXIDE; HYPERTENSION; MALE; MUSCLE, SKELETAL; OXIDATIVE STRESS; POLYETHYLENE GLYCOLS; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; TIRON; UP-REGULATION; VASOCONSTRICTION;

EID: 52449088341     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00205.2008     Document Type: Article

References (31)

1. Anborgh PH, Seachrist JL, Dale LB, Ferguson SS. Receptor/beta-arrestin complex formation and the differential trafficking and resensitization of beta2-adrenergic and angiotensin II type 1A receptors. Mol Endocrinol 14: 2040-2053, 2000.
2. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87: 840-844, 2000.
3. Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359: 995-1003, 2002.
4. Fox KM. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 362: 782-788, 2003.
5. Freel EM, Connell JM. Mechanisms of hypertension: the expanding role of aldosterone. J Am Soc Nephrol 15: 1993-2001, 2004.
6. Gao L, Wang W, Li YL, Schultz HD, Liu D, Cornish KG, Zucker IH. Sympathoexcitation by central ANG II: roles for AT1 receptor upregulation and NAD(P)H oxidase in RVLM. Am J Physiol Heart Circ Physiol 288: H2271-H2279, 2005.
7. Gunther S, Gimbrone MA Jr, Alexander RW. Regulation by angiotensin II of its receptors in resistance blood vessels. Nature 287: 230-232, 1980.
8. Hein L, Meinel L, Pratt RE, Dzau VJ, Kobilka BK. Intracellular trafficking of angiotensin II and its AT1 and AT2 receptors: evidence for selective sorting of receptor and ligand. Mol Endocrinol 11: 1266-1277, 1997.
9. Heistad DD, Lopez JA, Baumbach GL. Hemodynamic determinants of vascular changes in hypertension and atherosclerosis. Hypertension 17: III7-III11, 1991.
10. Huang A, Koller A. Endothelin and prostaglandin H2 enhance arteriolar myogenic tone in hypertension. Hypertension 30: 1210-1215, 1997.
11. Huang A, Sun D, Koller A. Endothelial dysfunction augments myogenic arteriolar constriction in hypertension. Hypertension 22: 913-921, 1993.
12. Hunyady L, Catt KJ, Clark AJ, Gaborik Z. Mechanisms and functions of AT(1) angiotensin receptor internalization. Regul Pept 91: 29-44, 2000.
13. Juul B, Aalkjaer C, Mulvany MJ. Responses of femoral resistance vessels to angiotensin in vitro. Eur J Pharmacol 135: 61-68, 1987.
14. Koller A, Huang A. Development of nitric oxide and prostaglandin mediation of shear stress-induced arteriolar dilation with aging and hypertension. Hypertension 34: 1073-1079, 1999.
15. Koller A, Huang A. Impaired nitric oxide-mediated flow-induced dilation in arterioles of spontaneously hypertensive rats. Circ Res 74: 416-421, 1994.
16. Lefkowitz RJ. G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization. J Biol Chem 273: 18677-18680, 1998.
17. Linder AE, Thakali KM, Thompson JM, Watts SW, Webb RC, Leite R. Methyl-beta-cyclodextrin prevents angiotensin II-induced tachyphylactic contractile responses in rat aorta. J Pharmacol Exp Ther 323: 78-84, 2007.
18. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 292: C82-C97, 2007.
19. Mulvany MJ. Structure and function of small arteries in hypertension. J Hypertens Suppl 8: S225-S232, 1990.
20. Mulvany MJ, Aalkjaer C. Structure and function of small arteries. Physiol Rev 70: 921-961, 1990.
21. Oeckler RA, Arcuino E, Ahmad M, Olson SC, Wolin MS. Cytosolic NADH redox and thiol oxidation regulate pulmonary arterial force through ERK MAP kinase. Am J Physiol Lung Cell Mol Physiol 288: L1017-L1025, 2005.
22. Price DA, Fisher ND. The renin-angiotensin system in blacks: active, passive, or what? Curr Hypertens Rep 5: 225-230, 2003.
23. Rhee SG, Kang SW, Jeong W, Chang TS, Yang KS, Woo HA. Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins. Curr Opin Cell Biol 17: 183-189, 2005.
24. Sorokin G, Grant NM, Egan BM, Lombard JH. Cyclooxygenase products do not modulate angiotensin II-induced contractions of human chorionic plate arteries. Am J Obstet Gynecol 167: 110-114, 1992.
25. Thakali K, Davenport L, Fink GD, Watts SW. Cyclooxygenase, p38 mitogen-activated protein kinase (MAPK), extracellular signal-regulated kinase MAPK, Rho kinase, and Src mediate hydrogen peroxide-induced contraction of rat thoracic aorta and vena cava. J Pharmacol Exp Ther 320: 236-243, 2007.
26. Ungvari Z, Csiszar A, Huang A, Kaminski PM, Wolin MS, Koller A. High pressure induces superoxide production in isolated arteries via protein kinase C-dependent activation of NAD(P)H oxidase. Circulation 108: 1253-1258, 2003.
27. Ungvari Z, Csiszar A, Kaminski PM, Wolin MS, Koller A. Chronic high pressure-induced arterial oxidative stress: involvement of protein kinase C-dependent NAD(P)H oxidase and local renin-angiotensin system. Am J Pathol 165: 219-226, 2004.
28. Vicaut E, Montalescot G, Hou X, Stucker O, Teisseire B. Arteriolar vasoconstriction and tachyphylaxis with intraarterial angiotensin II. Microvasc Res 37: 28-41, 1989.
29. Weber M. The telmisartan programme of research tO show Telmisartan End-organ proteCTION (PROTECTION) programme. J Hypertens Suppl 21: S37-S46, 2003.
30. Wolin MS, Gupte SA, Oeckler RA. Superoxide in the vascular system. J Vasc Res 39: 191-207, 2002.
31. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342: 145-153, 2000.